Top Dangerous Vaccine Adjuvant Will Be Used for Elderly Flu Vaccinations

October 12, 2015December 10, 2018Vaccines

Total19
12
2
5
Like

Share via

The FDA has granted fast track approval for Swiss based Novartis’s flu shot that contains squalene as an adjuvant to boost what they consider an immune response.

Fast track approval is normally reserved for crucial emergencies during vaccine shortages. You might be aware that there is no shortage of flu vaccines and most hyped flu epidemics are bogus. (Source below, No More Fake News)

But what they call an immune response is mostly a localized cytokine response to toxic adjuvants and preservatives. But the process of creating a cellular memory to defend against future viral attacks is usually bypassed by vaccinating.

Widget not in any sidebars

That’s why getting a viral disease and recovering or even being exposed to one without falling ill grants lifetime immunity, and that’s how true “herd immunity” can occur.

Squalene was used for troop anthrax vaccinations during the Gulf War and has been associated with Gulf War Syndrome that affected thousands of American soldiers during the Gulf War, many of whom died from that alone, exceeding combat fatalities.

The squalene paradox is that squalene oil appears naturally in our bodies to help manufacture vitamin D and is enhanced by some poly-unsaturated fats such as olive oil. But injecting the synthetic squalene is a different matter.

Squalene by injection causes the body to create an antibody response without boundaries. It’s called a cytokine storm.

The antibodies gather and attack all the body’s natural squalene, creating autoimmune diseases ranging from rheumatism to partial or complete paralysis and even death. This outcome was common during the 1976 national fake swine flu epidemic that spawned a very strong vaccination push.

Even President Ford rolled up his sleeve on live TV nationally. Not sure what was in the syringe though.

The lawsuits from so many deaths and Gillian Barre’ Syndrome (GBS) episodes from that vaccination push spurred legislation to indemnify vaccine makers from being sued, leading to the current National Vaccine Injury Compensation Program (NVICP), a no-fault alternative to the traditional tort system for resolving vaccine injury claims, which the U.S. Court of Federal Claims decides for whom to award financial compensation.

Immediate Squalene in Vaccine Concerns

No one should take the swine flu vaccine–it is one of the most dangerous vaccines ever devised. It contains an immune adjuvant called squalene (MF-59) which has been shown to cause severe autoimmune disorders such as MS, rheumatoid arthritis and Lupus. This is the vaccine adjuvant that is strongly linked to the Gulf War syndrome, which killed over 10,000 soldiers and caused a 200% increase in the fatal disease ALS (Lou Gehreg disease). – Dr. Russell Blaylock

Squalene was disallowed as an adjuvant for most vaccines for some time. Now we have the Swiss based pharmaceutical giant Novartis getting fast track approval for their latest seasonal flu shot vaccine with squalene designed for older people called Fluad.

It’s known that the combination of squalene and Polysorbate 80, a common surfactant used in vaccines, blows open the blood brain barrier to allow all that aluminum and/or Thimerasol (mercury) to enter the brain and help create dementia or other debilitating neurological diseases.

Barbara Loe Fisher, co-founder and president of non-profit NGO National Vaccine Information Center (NVIC) took the challenge against Novartis’s fast track approval. Here’s what she asserted:

Novartis failed to demonstrate that squalene adjuvanted Fluad was more effective or safer than an unadjuvanted influenza vaccine in the small clinical trial being used to justify accelerated licensure. In fact, Fluad was shown to be far more reactive and, in some studies, the vaccine was associated with even more serious reactions in the elderly when given a second time.

During the FDA advisory committee’s public comment time, Barbara continued her protest, commenting:

Why does Fluad need to be fast tracked to licensure for the elderly without additional evidence? There is public concern that fast tracking Fluad is really about fast tracking MF59 to licensure so it can be added to lots of new vaccines targeting infants, pregnant women and every American without adequate evidence for safety or effectiveness. (Emphasis added)

Incidentally, Italy halted Novartis Fluad trials because a couple of elderly trial subjects died during testing. And there were not that many in the trial at that time.

When two MDs who are not anti-vaccination warn against flu shots, as the two videos below show, it’s time to avoid them.